MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 7726-7734

  Zhao, Zhengyuan ^a   Liu, Juntao ^a   Wang, Changlei ^a   Wang, Yi ^a   Jiang, Youguo ^a   Guo, Min ^a  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

CDK2; Cyclin E2; miR 25; SCLC

Indexed keywords

CCNE2 PROTEIN, HUMAN; CYCLINE; MICRORNA; MIRN25 MICRORNA, HUMAN;

CELL CYCLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SMALL CELL LUNG CANCER; TUMOR CELL LINE;

CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; SMALL CELL LUNG CARCINOMA;

EID: 84920115617     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Devesa SS, Bray F, Vizcaino AP and Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 294-299.
3. Ridge CA, McErlean AM and Ginsberg MS. Epidemiology of lung cancer. Semin Intervent Radiol 2013; 30: 93-98.
4. Chan BA and Coward JI. Chemotherapy advances in small-cell lung cancer. J Thorac Dis 2013; 5 Suppl 5: S565-578.
5. Lally BE, Urbanic JJ, Blackstock AW, Miller AA and Perry MC. Small cell lung cancer: have we made any progress over the last 25 years? Oncologist 2007; 12: 1096-1104.
6. Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
7. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-677.
8. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ and Hammond SM. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
9. Hwang HW and Mendell JT. MicroRNAs in cell proliferation, cell death and tumorigenesis. Br J Cancer 2006; 94: 776-780.
10. Garzon R, Calin GA and Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60: 167-179.
11. Lynam-Lennon N, Maher SG and Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 2009; 84: 55-71.
12. Wang Y and Lee CG. MicroRNA and cancer--focus on apoptosis. J Cell Mol Med 2009; 13: 12-23.
13. Ma J, Dong C and Ji C. MicroRNA and drug resistance. Cancer Gene Ther 2010; 17: 523-531.
14. Nordentoft I, Birkenkamp-Demtroder K, Agerbaek M, Theodorescu D, Ostenfeld MS, Hartmann A, Borre M, Orntoft TF and Dyrskjot L. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genomics 2012; 5: 40.
15. Singh S, Chitkara D, Kumar V, Behrman SW and Mahato RI. miRNA profiling in pancreatic cancer and restoration of chemosensitivity. Cancer Lett 2013; 334: 211-220.
16. Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ and Green JE. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics 2011; 4: 79.
17. Zhang H, Zuo Z, Lu X, Wang L, Wang H and Zhu Z. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 2012; 27: 594-598.
18. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC and Ford HL. The miR-106b-25 cluster targets Smad7, activates TGF-ß signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012; 31: 5162-5171.
19. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG and Tan TM. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-1242.
20. Tan W, Li Y, Lim SG and Tan TM. miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol 2014; 20: 5962-5972.
21. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J and Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
22. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM and Wang E. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010; 16: 430-441.
23. Hwang HC and Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24: 2776-2786.
24. Santamaria D and Ortega S. Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 2006; 11: 1164-1188.
25. Caldon CE, Sergio CM, Kang J, Muthukaruppan A, Boersma MN, Stone A, Barraclough J, Lee CS, Black MA, Miller LD, Gee JM, Nicholson RI, Sutherland RL, Print CG and Musgrove EA. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells. Mol Cancer Ther 2012; 11: 1488-1499.
26. Caldon CE and Musgrove EA. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 2010; 5: 2.
27. Muller-Tidow C, Metzger R, Kugler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B, Schneider PM, Koeffler HP, Berdel WE and Serve H. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 2001; 61: 647-653.
28. Miko E, Czimmerer Z, Csanky E, Boros G, Buslig J, Dezso B and Scholtz B. Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 2009; 35: 646-664.
29. Gudas JM, Payton M, Thukral S, Chen E, Bass M, Robinson MO and Coats S. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol 1999; 19: 612-622.